logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Flourish Research - Miami

+13059202020
Source: Site record.
https://flourishresearch.com/locations/miami-little-havana

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

Flourish Research - Miami: Leading Multi-Therapeutic Research Site in South Florida Originally established in 2004 as Suncoast Research Group, Flourish Research - Miami has evolved into a prominent multi-therapeutic site specializing in Cardiovascular/Metabolic/Kidney, Neuroscience, and Infectious Diseases. With a dedicated team of investigators and an in-patient unit, we offer comprehensive research capabilities. Founded by Marco Ramirez and Dr. Mark Kutner, our site excels at serving underserved minority communities in South Florida. Join us at Flourish - Miami and be part of groundbreaking medical research.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Google. Medical Center
Source: Google. Medical group
Source: Google. Medical office
Source: Trial-derived.
14Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
12Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
21Unique Conditions
Source: Trial-derived.
12Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Obesity (3)Source: Trial-derived. Atherosclerotic Cardiovascular Disease (ASCVD) (2)Source: Trial-derived. Influenza (2)Source: Trial-derived. Overweight (2)Source: Trial-derived. Chronic Kidney Disease (CKD) (1)Source: Trial-derived. Chronic Low-back Pain (1)Source: Trial-derived. Chronic Low Back Pain (CLBP) (1)Source: Trial-derived. COPD (1)

Sponsors

Source: Trial-derived. Eli Lilly and Company (5)Source: Trial-derived. Pfizer (2)Source: Trial-derived. AbbVie (1)Source: Trial-derived. BioNTech SE (1)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)Source: Trial-derived. ModernaTX, Inc. (1)Source: Trial-derived. National Heart, Lung, and Blood Institute (NHLBI) (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic participant diary (eDiary/ePRO)
Source: AI-inferred. Electronic participant diary (ePRO) system
Source: AI-inferred. Virus neutralisation antibody assay